|
| Tarcine BioMed Inc., www.tarcine.com, is a medical diagnostic company, located in China (Zhongguancun Life Science Park, Beijing), offering affordable and accurate diagnostic solutions for the early detection and prevention of diseases. The company was founded in 2005 by a group of US-educated Chinese scientists based on molecular biology, cellular biology and immunology. The company's core activities include discovery, manufacturing and marketing of novel non-invasive diagnostic reagents for the early detection and screening of life-threatening diseases. Tarcine’s initial focus will be on the SFDA regulatory approval and commercialization of their nasopharyngeal carcinoma (NPC), kidney transplant rejection, and bladder cancer diagnostic kits.
...[More] |
|
